Recursion Pharmaceuticals, Inc. (RXRX) Technical Analysis

🔺 Technical Setup

📊 Technical Summary

Recursion Pharmaceuticals, Inc. (RXRX) closed at 3.46 (+4.85%). Price has recovered above the 50-day average but remains below the 200-day average, so the short-term tone is improving while the larger structure is still rebuilding. 20-day momentum is notably strong at +13.07%, with price is trading in the lower part of its roughly 52-week range (2.84–6.79), while ATR14 volatility is elevated at roughly 5.96% of price. RSI(14) is 50.3, leaving momentum in a fairly neutral range. RSI has been trending higher in recent sessions, indicating improving momentum conditions. MACD remains below its signal line, which shows that momentum confirmation is still limited. The MACD histogram remains negative, suggesting momentum is still on the softer side. Nearby upside pressure sits around 3.53. A decisive move through that level would improve the short-term picture. Latest fundamentals snapshot: Revenue: 5.17M · Net income: -644.76M · EPS (basic): -0.36. The interactive view adds overlays, pattern context and broader chart structure for deeper review.

Explore more